An X-ray crystal structure-based understanding of the inhibition of the MDM2-p53 protein-protein interaction by isoindolinones

被引：0
|
作者：
Anil, B. [1 ]
Blackburn, E. [1 ]
Blackburn, T. [2 ]
Cully, S. [2 ]
Liu, J. [2 ]
Drummond, C. J. [2 ]
Endicott, J. A. [1 ]
Golding, B. T. [3 ]
Griffin, R. J. [2 ]
Haggerty, K. [2 ]
Lunec, J. [2 ]
Newell, D. R. [2 ]
Revill, C. H. [2 ]
Riedinger, C. [1 ]
Watson, A. F. [2 ]
Xu, Q. [2 ]
Zhao, Y. [2 ]
Hardcastle, I. R. [2 ]
Noble, M. E. M. [1 ]
机构：
[1] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England
[2] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70402-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
276
引用
收藏
页码：91 / 92
页数：2
相关论文
共 50 条
  • [31] Structure-based inhibition of protein-protein interactions
    Watkins, Andrew M.
    Arora, Paramjit S.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 94 : 480 - 488
  • [32] A Fluorescent Probe for Imaging p53-MDM2 Protein-Protein Interaction
    Liu, Zhenzhen
    Miao, Zhenyuan
    Li, Jin
    Fang, Kun
    Zhuang, Chunlin
    Du, Lupei
    Sheng, Chunquan
    Li, Minyong
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (04) : 411 - 417
  • [33] The development of piperidinones as potent MDM2-P53 protein - protein interaction inhibitors for cancer therapy
    Liao, Guochao
    Yang, Deying
    Ma, Leilei
    Li, Wenwei
    Hu, Liqin
    Zeng, Liming
    Wu, Peng
    Duan, Lixin
    Liu, Zhongqiu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 159 : 1 - 9
  • [34] Small molecule protein-protein inhibitors for the p53-MDM2 interaction
    Dudkina, Anna S.
    Lindsley, Craig W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (10) : 952 - 960
  • [35] Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2-p53 and MDMX-p53 protein-protein interactions
    Blackburn, Tim J.
    Ahmed, Shafiq
    Coxon, Christopher R.
    Liu, Junfeng
    Lu, Xiaohong
    Golding, Bernard T.
    Griffin, Roger J.
    Hutton, Claire
    Newell, David R.
    Ojo, Stephen
    Watson, Anna F.
    Zaytzev, Andrey
    Zhao, Yan
    Lunec, John
    Hardcastle, Ian R.
    MEDCHEMCOMM, 2013, 4 (09) : 1297 - 1304
  • [36] Optimization beyond AMG 232: Discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein-protein interaction
    Wang, Yingcai
    Zhu, Jiang
    Liu, Jiwen
    Chen, Xiaoqi
    Mihalic, Jeff
    Deignan, Jeffrey
    Yu, Ming
    Sun, Daqing
    Kayser, Frank
    McGee, Lawrence R.
    Lo, Mei-Chu
    Chen, Ada
    Zhou, Jing
    Ye, Qiuping
    Huang, Xin
    Long, Alexander M.
    Yakowec, Peter
    Oliner, Jonathan D.
    Olson, Steven H.
    Medina, Julio C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (16) : 3782 - 3785
  • [37] Design and preclinical pharmacological evaluation of a cleavable succinate ester solubilizing group for isoindolinone MDM2-p53 protein-protein interaction inhibitors
    Zhao, Yan
    Thomas, Huw
    Liu, Junfeng
    Blackburn, Timothy J.
    Cully, Sarah
    Watson, Anna F.
    Hardcastle, Ian R.
    Golding, Bernard T.
    Griffin, Roger J.
    Lunec, John
    Newell, David R.
    CANCER RESEARCH, 2012, 72
  • [38] Discovery of AM-8553: Structure-based design of novel piperidinone inhibitors of the MDM2-p53 interaction
    Rew, Yosup
    Sun, Daqing
    De Turiso, Felix Gonzalez Lopez
    Bartberger, Michael D.
    Beck, Hilary P.
    Canon, Jude
    Chen, Ada
    Chow, David
    Deignan, Jeffrey
    Fox, Brian M.
    Gustin, Darin
    Huang, Xin
    Jiang, Min
    Jiao, Xianyun
    Jin, Lixia
    Kayser, Frank
    Kopecky, David J.
    Li, Yihong
    Lo, Mei-Chu
    Long, Alexander M.
    Michelsen, Klaus
    Oliner, Jonathan D.
    Osgood, Tao
    Ragains, Mark
    Saiki, Anne Y.
    Schneider, Steve
    Toteva, Maria
    Yakowec, Peter
    Yan, Xuelei
    Ye, Qiuping
    Yu, Dongyin
    Zhao, Xiaoning
    Zhou, Jing
    Medina, Julio C.
    Olson, Steven H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [39] Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction
    Neochoritis, Constantinos G.
    Atmaj, Jack
    Twarda-Clapa, Aleksandra
    Surmiak, Ewa
    Skalniak, Lukasz
    Koehler, Lisa-Maria
    Muszak, Damian
    Kurpiewska, Katarzyna
    Kalinowska-Tluscik, Justyna
    Beck, Barbara
    Holak, Tad A.
    Domling, Alexander
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 182
  • [40] Inhibition of the MDM2-p53 interaction as a potential target in cancer therapy
    Farnie, G
    Ahmed, S
    Lunec, J
    BRITISH JOURNAL OF CANCER, 2003, 88 : S34 - S34
12345